High-Quality STROMUSC MENT(Trestolone Acetate)50mg/ml For Bodybuilding CAS:6157-87-5
Trestolone Acetate, known colloquially in bodybuilding circles as MENT, represents one of the most potent synthetic anabolic-androgenic steroids ever developed. The acronym MENT derives from its chemical nomenclature—7α-Methyl-19-Nortestosterone—where "M" signifies the methyl group at the 7α position, "E" references the estrane base structure, "N" indicates the absence of the 19th carbon (nor configuration), and "T" denotes its testosterone-derived backbone. First synthesized in 1963, the compound remained largely forgotten for decades until pharmaceutical interest resurrected it for potential therapeutic applications.
The Compound's Identity and Origins
Trestolone Acetate, known colloquially in bodybuilding circles as MENT, represents one of the most potent synthetic anabolic-androgenic steroids ever developed. The acronym MENT derives from its chemical nomenclature-7α-Methyl-19-Nortestosterone-where "M" signifies the methyl group at the 7α position, "E" references the estrane base structure, "N" indicates the absence of the 19th carbon (nor configuration), and "T" denotes its testosterone-derived backbone. First synthesized in 1963, the compound remained largely forgotten for decades until pharmaceutical interest resurrected it for potential therapeutic applications.
Chemically designated as 7α-methylestr-4-en-17β-ol-3-one 17β-acetate, Trestolone Acetate is a 19-nor derivative belonging to the same steroid family as Nandrolone and Trenbolone. However, it possesses a critical distinction that sets it apart from other 19-nors: the 7α-methyl group prevents 5α-reduction while simultaneously enhancing androgen receptor binding affinity. This structural modification is the foundation of its extraordinary potency.
As a prodrug, Trestolone Acetate undergoes rapid hydrolysis following administration, converting to the active compound Trestolone (MENT). The acetate ester attached at the C17 position modulates its pharmacokinetics, providing controlled release and enhanced bioavailability following intramuscular injection. The 50mg/mL concentration is the most commonly encountered preparation in the non-clinical sphere, typically presented in 10mL multidose vials.
Pharmacological Features and Mechanism of Action
Androgen Receptor Affinity
The pharmacological profile of MENT is nothing short of remarkable. Its androgen receptor binding affinity is reported to be approximately 2.6 times that of 5α-dihydrotestosterone (DHT), with nuclear retention properties that further amplify its effects. The 7α-methylation serves multiple purposes: it increases androgen receptor affinity, hinders metabolic inactivation by reducing reduction of the delta-4 bond, and decreases affinity for sex hormone-binding globulin (SHBG). This means a greater proportion of the compound remains free and biologically active in circulation.
The Aromatization Paradox
Perhaps the most unique feature of MENT is its relationship with estrogen. Unlike other 19-nor compounds such as Nandrolone and Trenbolone, which do not aromatize significantly, MENT converts to 7α-methylestradiol-a potent estrogenic metabolite. This property makes MENT a hybrid compound: it delivers Trenbolone-like androgenic power while simultaneously providing its own estrogenic signal. This characteristic has led some advanced users to employ MENT as a standalone compound without a testosterone base, as it can theoretically fulfill both androgenic and estrogenic requirements for physiological function.
Progestogenic Activity
As a 19-nor derivative, MENT exhibits progestogenic activity, acting as an agonist of the progesterone receptor with binding affinity comparable to progesterone itself. This progestogenic component, combined with its estrogenic metabolite, creates a complex hormonal milieu that requires careful management.
Non-5-Alpha Reducible Nature
MENT does not interact with the 5-alpha reductase enzyme and therefore cannot convert to dihydrotestosterone (DHT). Its androgenic effects are entirely direct, mediated through the androgen receptor itself. This means that DHT-related side effects such as prostate enlargement and male pattern baldness occur through a different mechanism than with compounds that convert to DHT.
Applications in Bodybuilding
Muscle Hypertrophy and Strength
In bodybuilding contexts, MENT has garnered a reputation for producing extraordinarily rapid and significant gains in both muscle mass and strength. Research literature suggests its anabolic potency may be up to ten times greater than testosterone. The compound creates a highly anabolic environment through increased protein synthesis and enhanced nitrogen retention within muscle cells.
The gains produced by MENT are often described as "wet" due to estrogenic water retention, resulting in significant muscle fullness and size. Users report extreme pumps during training sessions and a rapid visual transformation that can be observed within the first weeks of administration.
The "All-in-One" Phenomenon
MENT's ability to provide both its own androgenic-anabolic signal and its own estrogen has led to its use as a potential complete replacement for testosterone. Clinical investigations have explored MENT as a male contraceptive and as an alternative for testosterone replacement therapy. In the bodybuilding sphere, this has translated into cycles where MENT is run solo or as the primary anabolic agent without a traditional testosterone base-a practice that remains controversial but increasingly common among advanced users.
Stacking Considerations
MENT is frequently incorporated into stacks alongside other compounds. Common pairings include testosterone (at reduced doses), Nandrolone, and various orals. Some users employ MENT as a "complimentary" agent rather than the primary hypertrophic driver, using it to augment the effects of other compounds. The compound's versatility means it can be adapted to various stacking strategies depending on individual goals and tolerance.
Benefits: What Users Report
Rapid Mass Accretion
The most frequently cited benefit of MENT is the sheer speed of results. Users consistently report dramatic gains in both size and strength that manifest faster than with most other compounds. This rapid response makes MENT attractive for shorter cycles or for breaking through stagnation phases.
Sense of Well-Being and Libido
Unlike Trenbolone-which is notorious for causing mood disturbances, anxiety, and sleep disruption-MENT is often associated with a profound sense of well-being, confidence, and elevated libido. The combination of potent androgen receptor activation and sufficient estrogenic activity appears to create a favorable psychological state in many users.
Joint Health
The estrogenic metabolite 7α-methylestradiol may contribute to joint health through its effects on collagen synthesis and synovial fluid production. This is in contrast to non-aromatizing compounds that can lead to joint discomfort due to estrogen deficiency.
Lipid Profile
Some anecdotal reports suggest MENT has a relatively favorable impact on lipid profiles compared to other potent androgens. However, this should be interpreted with caution, as individual responses vary significantly, and the compound's estrogenic activity can influence lipoprotein metabolism in complex ways.
Dosage Guidelines
Beginner Range
For first-time users, conservative dosing is strongly advised. A common starting point is 25mg administered daily (ED). This allows the user to assess individual tolerance and gauge the compound's effects before considering dosage escalation. Some sources recommend beginning even lower, at approximately 10-20mg administered every two to three days.
Moderate Range
The standard effective dosage range for most users falls between 25-75mg daily (ED) or every other day (EOD), totaling 175-525mg per week. For many individuals, 25-50mg ED proves more than sufficient to achieve substantial results. The 50mg/mL concentration makes dosage calculation straightforward: 0.5mL to 1.0mL per injection depending on the chosen dose.
Advanced Range
Experienced users may push dosages toward 100mg daily, though this is generally not recommended for those unfamiliar with the compound. Total weekly doses in the 350-700mg range are encountered among advanced users, though side effect management becomes increasingly challenging at these levels.
Administration Frequency
Due to the acetate ester's short half-life, frequent administration is necessary to maintain stable blood plasma levels. Daily injections (ED) are the most common protocol, though some users opt for every-other-day (EOD) administration. EOD dosing at 50mg has been reported, but this may result in greater hormonal fluctuations.
Cycle Design and Duration
Cycle Length
Typical MENT cycles range from 4 to 12 weeks. Shorter cycles of 4-6 weeks are often recommended for first-time users or those seeking to minimize cumulative side effects. Longer cycles of 8-12 weeks are employed by more experienced users aiming for maximum tissue accretion.
First Cycle Protocol
A prudent approach for a first MENT cycle involves starting with 25mg daily for the initial two weeks, then gradually increasing to 50mg daily if side effects remain manageable. The cycle should not exceed 4-6 weeks for the inaugural run.
Stacked Cycle Example
For those incorporating MENT into a stack, a commonly cited protocol involves running 25mg/day or 50mg EOD of MENT for 3-4 weeks, after which additional compounds such as Nandrolone Phenylpropionate (NPP) at 25mg/day or 50mg EOD may be introduced. The total cycle duration typically extends to 8-10 weeks in such scenarios.
On-Cycle Support
Given MENT's estrogenic and progestogenic activity, on-cycle ancillary medications are essential. Aromatase inhibitors such as Anastrozole or Exemestane are often employed to manage estrogenic side effects. Prolactin management with compounds like Cabergoline or Pramipexole may also be necessary due to MENT's tendency to increase serum prolactin. Blood pressure monitoring is critical, as MENT can provoke significant increases in systolic blood pressure.
Half-Life and Pharmacokinetics
The Acetate Ester
The acetate ester attached to the trestolone molecule dictates its pharmacokinetic profile. Acetate esters are short-chain esters that result in rapid absorption, peak plasma concentrations, and relatively quick elimination. This stands in contrast to longer esters such as enanthate or cypionate, which provide more sustained release profiles.
Half-Life Estimates
The half-life of Trestolone Acetate has been subject to considerable debate within the bodybuilding community. Some sources suggest an extremely short half-life measured in minutes, while clinical sources indicate a more extended duration of 1-2 days. The discrepancy likely reflects differences between the active compound's intrinsic half-life and the practical duration of action following intramuscular administration.
The acetate ester provides a half-life that necessitates daily or every-other-day administration to maintain stable blood levels. This rapid clearance is actually advantageous for users who experience adverse effects, as discontinuation allows the compound to clear the system relatively quickly.
Detection and Clearance
The short half-life means that MENT is eliminated from the body more rapidly than longer-estered compounds. While this facilitates faster recovery of endogenous hormone production following cessation, it also means that consistent administration is required to maintain anabolic effects. Complete clearance from the body typically occurs within several days of the final injection, though metabolite detection windows may be longer.
Post-Cycle Therapy (PCT)
The Suppression Challenge
MENT is a profoundly suppressive compound, capable of inducing rapid and complete shutdown of the hypothalamic-pituitary-gonadal (HPG) axis. Its suppressive potency is comparable to the combination of testosterone and etonogestrel. This suppression is mediated through multiple mechanisms: estrogens exert negative feedback at the pituitary, androgens and estrogens slow hypothalamic GnRH secretion, and the compound's progestogenic activity further reinforces the suppressive signal.
PCT Initiation
Given MENT's short half-life, PCT should begin relatively soon after the final administration. For the acetate ester, a waiting period of 3-7 days after the last injection is typical before commencing PCT. This allows sufficient time for the exogenous compound to clear and for endogenous suppression to be addressed.
Standard PCT Protocol
A conventional PCT approach for MENT involves the use of selective estrogen receptor modulators (SERMs) to stimulate endogenous testosterone production. A commonly cited protocol consists of Tamoxifen at 20mg daily for two weeks, followed by 10mg daily for an additional two weeks. Some users incorporate human chorionic gonadotropin (hCG) during the latter stages of the cycle or in the transition period before SERM therapy to stimulate Leydig cell function.
Extended Recovery Considerations
The profound suppression induced by MENT means that recovery of natural testosterone production may be more challenging than with less suppressive compounds. Some users report persistent suppression even after standard PCT protocols. This has led some authorities to recommend extended PCT durations or the use of more aggressive protocols incorporating multiple SERMs or combination therapies.
Monitoring and Adjustment
Given the variability in individual responses, blood work is essential for guiding PCT. Monitoring total testosterone, free testosterone, LH, FSH, and estradiol levels allows for objective assessment of recovery progress and adjustment of PCT protocols accordingly.
Risk Considerations
Estrogenic Side Effects
MENT's conversion to 7α-methylestradiol creates significant potential for estrogenic side effects including gynecomastia, water retention, and blood pressure elevation. The estrogenic metabolite is reportedly potent, and some users describe MENT as creating more estrogen than any other steroid.
Prolactin-Related Issues
The progestogenic activity combined with prolactin elevation can lead to prolactin-induced gynecomastia and sexual dysfunction. This "double whammy" of estrogen and prolactin requires comprehensive management strategies.
Clinical Data
| Brand | STROMUSC |
|
Trade names |
Orgasteron acetate; MENT acetate; CDB-903; NSC-69948; U-15614; 7α-Methyl-19-nortestosterone 17β-acetate; 7α-Methylestr-4-en-17β-ol-3-one 17β-acetate |
|
CAS |
6157-87-5 |
|
Molar mass |
330.468 |
|
Formula |
C21H30O3 |
|
Purity |
Above 98% |
|
Apprarance |
50mg/ml |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785
Conclusion
Trestolone Acetate (MENT) at 50mg/mL represents one of the most potent anabolic agents available in the non-clinical sphere. Its unique pharmacological profile-combining extreme androgen receptor affinity, aromatization to a potent estrogen, and progestogenic activity-creates a compound of extraordinary power and complexity. The rapid gains in muscle mass and strength are matched by equally significant challenges in side effect management and post-cycle recovery.
The compound's history as a potential male contraceptive and TRT alternative underscores its potent suppressive effects on the HPG axis. This same property that makes it effective for contraception makes it one of the most challenging compounds for post-cycle recovery. The short acetate ester provides the advantage of rapid clearance should adverse effects emerge, but also demands disciplined administration schedules.
For those who choose to employ MENT, thorough preparation-including comprehensive on-cycle support, blood pressure monitoring, and a well-designed PCT protocol-is not optional but essential. The compound's power demands respect, and its risks require meticulous management. As with all potent anabolic agents, the decision to use MENT should be made with full awareness of both its remarkable capabilities and its significant potential for harm.
Hot Tags: high-quality stromusc ment(trestolone acetate)50mg/ml for bodybuilding cas:6157-87-5, China high-quality stromusc ment(trestolone acetate)50mg/ml for bodybuilding cas:6157-87-5 manufacturers, suppliers, factory
